Medtronic has announced a definitive agreement to acquire Scientia Vascular, a Salt Lake City-based medical device company, for $550 million plus undisclosed earn-out and milestone payments. The deal brings Scientia’s guidewire and catheter access products into Medtronic’s existing neurovascular suite, strengthening procedural workflow support for treating complex neurovascular conditions including stroke.
Scientia, which employs approximately 310 people, has developed an access platform designed to navigate the complexity of cerebral vasculature with improved efficiency. Stroke affects 12 million people globally each year, making rapid access to occlusion and aneurysm sites critical since every second of restricted blood flow results in the loss of millions of brain cells.
The transaction is expected to close in the first half of Medtronic’s fiscal year 2027, pending regulatory approvals. The company projects the deal will be minimally dilutive to adjusted earnings per share in FY27 and accretive thereafter.